SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-009113
Filing Date
2023-07-31
Accepted
2023-07-31 17:13:50
Documents
12
Period of Report
2023-07-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_072523.htm   iXBRL 8-K 29318
  Complete submission text file 0001387131-23-009113.txt   204599

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE admp-20230725_lab.xml EX-101.LAB 34240
3 XBRL PRESENTATION FILE admp-20230725_pre.xml EX-101.PRE 22385
4 XBRL SCHEMA FILE admp-20230725.xsd EX-101.SCH 2998
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_072523_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 231128374
SIC: 2834 Pharmaceutical Preparations